Cargando…
Human mesenchymal stem cells derived from amniotic membrane attenuate isoproterenol (ISO)-induced myocardial injury by targeting apoptosis
Background: Currently, stem cell therapy has been proposed as an efficient strategy to prevent or treat myocardial injuries. The current study was conducted to examine cardioprotective effects of human mesenchymal stem cells derived from amniotic membrane (hAMSCs) against isoproterenol (ISO)-induced...
Autores principales: | Kheila, Maryam, Gorjipour, Fazel, Hosseini Gohari, Ladan, Sharifi, Masoomeh, Aboutaleb, Nahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285550/ https://www.ncbi.nlm.nih.gov/pubmed/34291006 http://dx.doi.org/10.47176/mjiri.35.82 |
Ejemplares similares
-
Amniotic Membrane-Derived Mesenchymal Stem Cells for Heart Failure: A Systematic Review and Meta-Analysis of the Published Preclinical Studies
por: Gorjipour, Fazel, et al.
Publicado: (2021) -
Mesenchymal stem cells from human amniotic membrane differentiate into cardiomyocytes and endothelial-like cells without improving cardiac function after surgical administration in rat model of chronic heart failure
por: Gorjipour, Fazel, et al.
Publicado: (2019) -
Human amniotic membrane mesenchymal stem cells-conditioned medium attenuates myocardial ischemia-reperfusion injury in rats by targeting oxidative stress
por: Mokhtari, Behnaz, et al.
Publicado: (2020) -
Conditioned medium obtained from human amniotic membrane-derived mesenchymal stem cell attenuates heart failure injury in rats
por: Nasseri Maleki, Solmaz, et al.
Publicado: (2019) -
Sulforaphane Attenuates Isoproterenol-Induced Myocardial Injury in Mice
por: Song, Lijuan, et al.
Publicado: (2020)